abstract |
The present invention relates to the therapeutic use of novel stabilized oligoribonucleotides as immunomodulators for immunotherapeutic applications. Specifically, the present invention provides novel RNA based oligoribonucleotides having improved nuclease and RNase stability with immunomodulatory activity via TLR7 and / or TLR8. |